Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03909334
Title Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Xiuning Le
Indications

lung non-squamous non-small cell carcinoma

Therapies

Osimertinib + Ramucirumab

Osimertinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.